Kaopiz Signs MOU with Singapore's QuantumTX in Preventive Healthcare Technology

Key facts

  • Kaopiz Signs MOU with Singapore's QuantumTX in Preventive Healthcare Technology
  • Kaopiz Holdings, a Vietnamese IT software development company, signed a Memorandum of Understanding (MOU) with Singapore's QuantumTX Pte. Ltd. on May 29, 2026, at the Vietnam-Singapore Technology Collaboration Forum in Singapore. The partnership combines QuantumTX's proprietary muscle and mitochondrial activation technology, 'MitoCharge,' with Kaopiz's expertise in medical software development and IoT engineering. The companies will jointly develop IoT device control software, health data collection and processing platforms, mobile applications, and remote device management systems. The signing ceremony was witnessed by Singapore's Minister for Manpower and Energy, Science and Technology, Tan See Leng, and Vietnam's General Secretary and President, To Lam.
  • Source: PR Times
  • Date: June 3, 2026

Direct answer

Kaopiz Holdings, a Vietnamese IT software development company, signed a Memorandum of Understanding (MOU) with Singapore's QuantumTX Pte. Ltd. on May 29, 2026, at the Vietnam-Singapore Technology Collaboration Forum in Singapore. The partnership combines QuantumTX's proprietary muscle and mitochondrial activation technology, 'MitoCharge,' with Kaopiz's expertise in medical software development and IoT engineering. The companies will jointly develop IoT device control software, health data collection and processing platforms, mobile applications, and remote device management systems. The signing ceremony was witnessed by Singapore's Minister for Manpower and Energy, Science and Technology, Tan See Leng, and Vietnam's General Secretary and President, To Lam.

Citation
Kaopiz Signs MOU with Singapore's QuantumTX in Preventive Healthcare Technology (June 3, 2026), PR Times
Source
PR Times
Date
June 3, 2026
Kaopiz Holdings, a Vietnamese IT software development company, signed a Memorandum of Understanding (MOU) with Singapore's QuantumTX Pte. Ltd. on May 29, 2026, at the Vietnam-Singapore Technology Collaboration Forum in Singapore. The partnership combines QuantumTX's proprietary muscle and mitochondrial activation technology, 'MitoCharge,' with Kaopiz's expertise in medical software development and IoT engineering. The companies will jointly develop IoT device control software, health data collection and processing platforms, mobile applications, and remote device management systems. The signing ceremony was witnessed by Singapore's Minister for Manpower and Energy, Science and Technology, Tan See Leng, and Vietnam's General Secretary and President, To Lam.
提携NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 3, 2026 at 10:00
  • 🔍 Collected: June 3, 2026 at 10:25 (25 min after Published)
  • 🤖 AI Analyzed: June 7, 2026 at 01:41 (87h 15m after Collected)
Kaopiz Holdings (hereinafter referred to as Kaopiz), a Vietnamese IT software development company, signed a Memorandum of Understanding (MOU) with Singapore's QuantumTX Pte. Ltd. on May 29, 2026, at the 'Vietnam-Singapore Technology Collaboration Forum' held in Singapore. This agreement marks the first step in a strategic collaboration aimed at jointly developing next-generation preventive healthcare solutions to address the rapidly progressing global aging population.

■ Background of the Signing

The MOU was signed by Kaopiz Holdings CEO Le Van Hoang and QuantumTX CEO Ivan Goh at the Raffles City Convention Centre in Singapore, in the presence of Singapore's Minister for Manpower and Minister-in-charge of Energy, Science and Technology, Tan See Leng, and Vietnam's General Secretary and President, To Lam.

The forum was co-organized by Vietnam's Ministry of Foreign Affairs, Ministry of Science and Technology, Ministry of Finance, VSIP, and Enterprise Singapore, and was held as part of an official visit to Singapore. It served as a high-level platform bringing together government officials, research institutions, and businesses from both countries to promote cooperation in science, technology, innovation, and sustainable development.

Kaopiz Holdings CEO Le Van Hoang (left) and QuantumTX CEO Ivan Goh (right)

■ Collaboration Details – Strategic Partnership in Preventive Healthcare Technology

This collaboration combines QuantumTX's proprietary muscle and mitochondrial activation technology, 'MitoCharge,' with Kaopiz's proven track record in medical software development and IoT engineering. MitoCharge is a technology that delivers physiological effects equivalent to exercise without physical strain.

The companies will jointly develop personalized health solutions, including IoT device control software, health data collection and processing platforms, mobile applications, and remote device management systems.

The collaboration is structured around three pillars:

IoT Device and Software Development: Kaopiz will handle the research, design, development, and maintenance of software that interfaces with QuantumTX's IoT devices, contributing to the medical and rehabilitation fields.

Technical Support and Information Exchange: Kaopiz will support the integration of advanced technologies such as AI, cloud computing, and data analytics into QuantumTX's medical device ecosystem, and both companies will work to ensure compliance with medical data security standards.

Market Development: Both companies will jointly deploy solutions in Vietnam, Singapore, and international markets, and will participate together in relevant medical technology projects, academic conferences, and exhibitions.

■ Management Comments

Kaopiz Holdings CEO Le Van Hoang stated: 'Aging is a common challenge that both Vietnam and Singapore need to solve, and we believe technology holds the key. Kaopiz will leverage its expertise in software, AI, and IoT to the fullest, jointly developing next-generation medical solutions with QuantumTX to contribute to people around the world.'

QuantumTX CEO Ivan Goh commented: 'This collaboration with Kaopiz will accelerate the development of our next-generation products and open the door to bringing MitoCharge technology to users in Vietnam and across Southeast Asia.'

Kaopiz Global CEO Nguyen Cong Thanh stated: 'The fusion of QuantumTX's innovative hardware technology and Kaopiz's software technology will create groundbreaking medical products that contribute to people in Singapore and around the world.'

■ Future Outlook

The signing of this MOU demonstrates Kaopiz's ongoing commitment to expanding its business in the global medical technology field and reflects Vietnam's growing presence in the international community as a partner with high added value and innovation.

Kaopiz will continue to strengthen its business base in Singapore while collaborating with an increasing number of overseas companies. It aims to advance the development of core software solutions and the implementation of cutting-edge AI technologies, striving to remain a technology partner that creates tangible value in people's daily lives, from healthcare to digital infrastructure.

【Company Profile】

Company Name: Kaopiz Co., Ltd.

Location: 3-8-8-3F Minamiikebukuro, Toshima-ku, Tokyo

Established: August 2016 (Hanoi Headquarters: September 29, 2014)

Representative Director: TRINH CONG HUAN

Number of Employees: 810 (as of June 2026 / Group total)

Business Description: Technology consulting, new development, server migration, AI solutions, research and development, etc.

Website: https://kaopiz.com/

Contact: https://kaopiz.com/ja-contact/

Tel: 03-5809-2633 Business Hours: 10:00-18:00 (Closed on weekends and holidays)

FAQ

What is the main purpose of this MOU?

To jointly develop next-generation preventive healthcare solutions for the global aging population.

What is MitoCharge?

A muscle and mitochondrial activation technology developed by QuantumTX that provides physiological effects equivalent to exercise without physical strain.

What are Kaopiz's strengths?

Proven track record in medical software development, IoT engineering, AI, cloud computing, and data analytics.